Alan Fuhrman - Net Worth and Insider Trading
Alan Fuhrman Net Worth
The estimated net worth of Alan Fuhrman is at least $211,495 dollars as of 2024-11-05. Alan Fuhrman is the CFO of Tyra Biosciences Inc and owns about 12,849 shares of Tyra Biosciences Inc (TYRA) stock worth over $211,495. Alan Fuhrman is also the Director of Loxo Oncology Inc and owns about 0 shares of Loxo Oncology Inc (LOXO) stock worth over $0. Details can be seen in Alan Fuhrman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alan Fuhrman has not made any transactions after 2024-10-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Alan Fuhrman
Alan Fuhrman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alan Fuhrman owns 7 companies in total, including Checkmate Pharmaceuticals Inc (CMPI) , Esperion Therapeutics Inc (ESPR) , and SpringWorks Therapeutics Inc (SWTX) among others .
Click here to see the complete history of Alan Fuhrman’s form 4 insider trades.
Insider Ownership Summary of Alan Fuhrman
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CMPI | Checkmate Pharmaceuticals Inc | 2020-08-06 | director |
ESPR | Esperion Therapeutics Inc | 2020-03-16 | director |
SWTX | SpringWorks Therapeutics Inc | 2020-05-20 | director |
2019-02-15 | director | ||
2015-09-30 | Chief Financial Officer | ||
2004-09-15 | Senior Vice President & CFO | ||
2023-01-01 | Chief Financial Officer |
Alan Fuhrman Latest Holdings Summary
Alan Fuhrman currently owns a total of 2 stocks. Among these stocks, Alan Fuhrman owns 12,849 shares of Tyra Biosciences Inc (TYRA) as of October 30, 2024, with a value of $211,495 and a weighting of 100%. Alan Fuhrman also owns 0 shares of Loxo Oncology Inc (LOXO) as of June 8, 2018, with a value of $0 and a weighting of 0%.
Latest Holdings of Alan Fuhrman
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TYRA | Tyra Biosciences Inc | 2024-10-30 | 12,849 | 16.46 | 211,495 |
LOXO | Loxo Oncology Inc | 2018-06-08 | 0 | 234.66 | 0 |
Holding Weightings of Alan Fuhrman
Alan Fuhrman Form 4 Trading Tracker
According to the SEC Form 4 filings, Alan Fuhrman has made a total of 1 transactions in Tyra Biosciences Inc (TYRA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Tyra Biosciences Inc is the acquisition of 9,500 shares on October 30, 2024, which cost Alan Fuhrman around $152,000.
According to the SEC Form 4 filings, Alan Fuhrman has made a total of 0 transactions in Loxo Oncology Inc (LOXO) over the past 5 years. The most-recent trade in Loxo Oncology Inc is the sale of 2,625 shares on June 8, 2018, which brought Alan Fuhrman around $467,434.
Insider Trading History of Alan Fuhrman
- 1
Alan Fuhrman Trading Performance
Alan Fuhrman Ownership Network
Ownership Network List of Alan Fuhrman
Ownership Network Relation of Alan Fuhrman
Alan Fuhrman Owned Company Details
What does Checkmate Pharmaceuticals Inc do?
Who are the key executives at Checkmate Pharmaceuticals Inc?
Alan Fuhrman is the director of Checkmate Pharmaceuticals Inc. Other key executives at Checkmate Pharmaceuticals Inc include 10 percent owner Venbio Global Strategic Fund Ii L.p. , director & Chief Executive Officer Alan Bash , and 10 percent owner Novo Holdings A/s .
Checkmate Pharmaceuticals Inc (CMPI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Checkmate Pharmaceuticals Inc (CMPI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Checkmate Pharmaceuticals Inc (CMPI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Checkmate Pharmaceuticals Inc (CMPI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Checkmate Pharmaceuticals Inc Insider Transactions
Alan Fuhrman Mailing Address
Above is the net worth, insider trading, and ownership report for Alan Fuhrman. You might contact Alan Fuhrman via mailing address: C/o Ambit Biosciences Corporation, 11080 Roselle Street, San Diego Ca 92121.